戻る Agenda
Session 1: Panel Discussion
Speaker(s)
Mark Bach, MD, PhD
Johnson & Johnson, United States
Vice President, Office of the Chief Medical Officer
Yasuto Otsubo
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Review Director, Office of New Drug II
Ling Su, PhD
Yeehong Business School, China
Research Fellow
Mee Ryung Ahn, PhD
Ministry of Food and Drug Safety, Korea, Republic of
Director
Li-Li Su
Center for Drug Evaluation, Taiwan
Reviewer, Division of Pharmaceutical Sciences
Yoshiaki Uyama, PhD, MS, RPh
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Associate Executive Director